View Cart (0 items)

Articles Tagged with ''pharmaceutical industry''

Bristol-Myers Squibb to build new biologics manufacturing plant in Ireland

The new manufacturing facility will produce multiple therapies for the biopharmaceutical company's growing portfolio of approved and investigational biologic medicines in therapeutic areas including oncology, virology and immunoscience.
Read More

Allergan enters acquisition deal with Actavis

Botox maker Allergan, Inc. will be acquired by Actavis plc for $66 billion after fending off a hostile takeover bid by activist investor William Ackman and Valeant Pharmaceuticals International Inc.
Read More

Banned drugs found in dietary supplements after recalls

New research suggests that more rigorous regulatory oversight is needed in the dietary supplements industry.
Read More

Roche to make diagnostic products in China

Roche is to establish a new diagnostic manufacturing facility in China, investing 450 million Swiss francs ($463 million) over the next three years.
Read More

Bayer Healthcare closes Dihon acquisition, invests in Versant fund

Bayer HealthCare, part of German chemical and pharmaceutical group Bayer AG, has completed its acquisition of Chinese pharmaceutical company Dihon Pharmaceutical Group Co., Ltd.
Read More

GlaxoSmithKline plans stock market sale of minority stake in HIV treatment company

British pharmaceutical group GlaxoSmithKline plc (GSK) is planning to spin off a subsidiary that focuses on developing treatments for HIV.
Read More

Novartis to sell influenza vaccines business for $275 million

Healthcare company Novartis has entered into an agreement to sell its influenza vaccines unit for $275 million.
Read More

Three Nigerian pharmaceutical firms get WHO certification

Three pharmaceutical manufacturers in Nigeria have been certified by the World Health Organization (WHO) to produce drugs in accordance with its Good Manufacturing Practice (GMP).
Read More

Auxilium Pharmaceuticals agrees to acquisition deal with Endo

Specialty biopharmaceutical company Auxilium Pharmaceuticals, Inc. is to be acquired by Endo International plc for $2.6 billion, including the repayment and assumption of debt.
Read More

Teva to end cancer, women's health research

Generic drugmaker Teva Pharmaceutical Industries Ltd. has decided to stop research and development in a number of areas, including oncology and women's health, as part of efforts to cut costs.
Read More